UROMAX ULTRA BALLOON CATHETER
Report
- Report Number
- 3005099803-2008-05073
- Event Type
- Malfunction
- Date Received
- October 6, 2008
- Date of Event
- July 4, 2008
- Report Date
- September 9, 2008
- Manufacturer
- BOSTON SCIENTIFIC
- Product Code
- EZN
- PMA / PMN Number
- K980795
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- HK
- Reporter Occupation
- PHYSICIAN
Narratives
DEVICE ANALYSIS: VISUAL AND MICROSCOPIC EXAMINATION OF THE RETURNED DEVICE REVEALED NO DAMAGE TO THE SHAFT OF THE DEVICE. THE BALLOON WAS FOLDED BUT NOT WRAPPED AROUND THE SHAFT. THERE WERE 2 PINHOLES VISIBLE IN THE BALLOON MATERIAL APPROXIMATELY 15MM PROXIMAL TO THE TIP OF THE DEVICE WHEN THE BALLOON WAS INFLATED TO ITS RATED BURST PRESSURE. THE SURROUNDING BALLOON MATERIAL DID NOT CONTAIN ANY ABNORMALITIES WHICH MAY HAVE CONTRIBUTED TO THE DEFECT. DEVICE HISTORY RECORD REVIEW WAS PERFORMED AND NO ISSUES WERE NOTED. THE MOST PROBABLE ROOT CAUSE OF THE REPORTED EVENT WAS DETERMINED TO BE HANDLING DAMAGE BECAUSE THE COMPLAINT WAS CAUSED BY HANDLING OF THE DEVICE WITHOUT PT CONTACT.
THIS COMPLAINT IS NOW REPORTABLE BASED ON INFO OBTAINED DURING THE DEVICE ANALYSIS IN 2008. IT WAS REPORTED THAT DURING A URETERAL STENTING PROCEDURE, THE BALLOON FAILED TO INFLATE. THE TARGET LESION WAS IN AN UNSPECIFIED URETERAL LOCATION. A U2Q/6-4/5.8/75 UROMAX ULTRA BALLOON CATHETER HAD BEEN UNPACKED AND TESTED; HOWEVER, THE BALLOON FAILED TO INFLATE. THE PHYSICIAN CHOSE NOT TO USE THE BALLOON TO PREDILATE THE LESION. THE BALLOON CATHETER DID NOT COME INTO CONTACT WITH THE PT. THE PROCEDURE WAS COMPLETED WITH DIRECT STENTING USING AN UNSPECIFIED TYPE OF 7 FRENCH URETERAL STENT. THERE WERE NO PT COMPLICATIONS REPORTED WITH THE PT'S CURRENT CONDITION LISTED AS "STABLE". RETURNED PROD ANALYSIS REVEALED 2 PINHOLES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | UROMAX ULTRA BALLOON CATHETER | EZN | BOSTON SCIENTIFIC | M0062251020 | 8003608 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 65 YR |